{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:21Z","timestamp":1793390841907,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is a common, but clinically heterogeneous, condition. This study explores PCOS subtypes using two orthogonal statistical analyses of biochemical and anthropometric data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Unsupervised hierarchical cluster analysis and principal component analysis (PCA) of hormonal and metabolic parameters were performed in a cohort of PCOS-affected women, diagnosed based on the NIH criteria. Data collected included body mass index (BMI), blood pressure (BP), fasting insulin and glucose (HOMA-IR), gonadotropins, androgens, and lipids. Subtypes were explored using unsupervised hierarchical cluster analysis, grouping both phenotypic variables and patients into clusters. PCA resolved correlated variables (excluding BMI) into independent factors, and the influence of BMI on the components was then explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One thousand and thirty-five women with PCOS were included in the study, with 975 assessed using cluster analysis and PCA. Two main clusters of variables were evident: one characterized by BP, BMI, HOMA-IR, and lipids (triglycerides\/cholesterol\/LDL) and the second by LH: FSH, androgens, SHBG, and HDL. Three separate patient clusters emerged: cluster A (29.6% of women) showed higher BP, BMI, HOMA-IR, and lipids (triglycerides\/cholesterol\/LDL) and lower LH: FSH, SHBG, and HDL. Cluster C (43.3%) showed lower BP, BMI, HOMA-IR, triglycerides, testosterone, and FAI and higher LH: FSH, DHEAS, androstenedione, 17-hydroxyprogesterone, SHBG, and HDL. Cluster B (27.1%) was intermediate. Two components aligned with the cluster analysis: principal component (PC) 1, including HOMA-IR, systolic and diastolic BP, triglycerides, LDL, FAI, and SHBG, was positively correlated with BMI (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>= 0.32, <jats:italic>p<\/jats:italic>-value &amp;lt; 0.0001) and aligned with cluster A. PC2, influenced by testosterone, LH: FSH, FAI, DHEAS, androstenedione, and 17-hydroxyprogesterone, with loadings in the opposite direction from LDL and cholesterol, aligned with cluster C, with little relationship with BMI (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>= 0.0067, <jats:italic>p<\/jats:italic>-value = 0.0107).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Different metabolic and reproductive PCOS subtypes are evident. Androstenedione and 17-hydroxyprogesterone are important in the reproductive phenotype, highlighting the importance of these hormones in diagnosis and subtype identification and emphasizing their significance in understanding PCOS biology as a predominantly hyperandrogenic disorder. BMI influences and exacerbates the metabolic subtype; in the reproductive group and in lean\/normal BMI patients, there is little relationship between weight and other PCOS-related characteristics. Accordingly, traditional treatment paradigms cannot be generalized to all women, and these subtypes may ultimately be viewed as separate disorders<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1572427","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:14:07Z","timestamp":1760674447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Characterization of distinct polycystic ovary syndrome subtypes by cluster and principal component analyses"],"prefix":"10.3389","volume":"16","author":[{"given":"Kharis A.","family":"Burns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn G. A.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.05.004","article-title":"Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis","volume":"63","author":"Stuckey","year":"2014","journal-title":"Metabolism"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis","volume":"17","author":"Dapas","year":"2020","journal-title":"PloS Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0334","article-title":"Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-M\u00fcllerian hormone concentrations aggregate with the markers of hyperandrogenism","volume":"95","author":"Dewailly","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae298","article-title":"Clustering identifies subtypes with different phenotypic characteristics in women with polycystic ovary syndrome","author":"van der Ham","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","article-title":"Influence of anthropometric measurements on abnormal gonadotropin secretion in women with polycystic ovary syndrome","volume":"24","author":"Haider","year":"2014","journal-title":"J Coll Physicians Surg Pak"},{"key":"B6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.fertnstert.2014.04.004","article-title":"Assessment of insulin resistance in lean women with polycystic ovary syndrome","volume":"102","author":"Morciano","year":"2014","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den263","article-title":"Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons","year":"2008","journal-title":"Hum Reprod"},{"key":"B8","year":"2024","journal-title":"Overweight and obesity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"B10","doi-asserted-by":"publisher","first-page":"Cd007506","DOI":"10.1002\/14651858.CD007506.pub3","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"2","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0015-0282(16)56632-1","article-title":"Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women","volume":"61","author":"Guzick","year":"1994","journal-title":"Fertil Steril"},{"key":"B16","article-title":"Diagnostic criteria for polycystic ovary syndrome; towards a rational approach","volume-title":"Polycystic Ovary Syndrome","author":"Zawadski","year":"1992"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2004.10559","article-title":"Comparison of different methods for the measurement of serum testosterone in the aging male","volume":"134","author":"Christ-Crain","year":"2004","journal-title":"Swiss Med Wkly"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.12.030","article-title":"Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs)","volume":"430","author":"Bestwick","year":"2014","journal-title":"Clin Chim Acta"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.10.1138","article-title":"A prospective analysis of the HOMA model. The Mexico City Diabetes Study","volume":"19","author":"Haffner","year":"1996","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.13140\/RG.2.2.20143.36007","article-title":"ClustImpute: an R package for k-means clustering with build-in missing data imputation","volume":"13","author":"Pfaffel","year":"2020"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1963.10500845","article-title":"Hierarchical grouping to optimize an objective function","volume":"58","author":"Ward","year":"1963","journal-title":"J Am Stat Assoc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward\u2019s hierarchical agglomerative clustering method: which algorithms implement Ward\u2019s Criterion","volume":"31","author":"Murtagh","year":"2014","journal-title":"J Classif"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-21706-2","volume-title":"Modern applied statistics with S","author":"Venables","year":"2002"},{"key":"B27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.fertnstert.2013.08.056","article-title":"The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial","volume":"101","author":"Legro","year":"2014","journal-title":"Fertil Steril"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2004.05.002","article-title":"The genetics of polycystic ovary syndrome","volume":"18","author":"Amato","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(92)91779-a","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1997.273.4.E708","article-title":"Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity","volume":"273","author":"Koyama","year":"1997","journal-title":"Am J Physiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"14156","DOI":"10.1038\/s41598-017-14534-2","article-title":"Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome","volume":"7","author":"Deng","year":"2017","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome: which criteria to use and when","volume":"50","author":"Chang","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad377","article-title":"Serum 21-deoxycortisol for diagnosis of non-classic congenital adrenal hyperplasia in women with androgen excess","author":"Ng","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000334","article-title":"Clinical significance of 11-oxygenated androgens","volume":"24","author":"Turcu","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment","volume":"14","author":"Xing","year":"2022","journal-title":"Int J Womens Health"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12830","article-title":"The association between polycystic ovary syndrome (PCOS) and metabolic syndrome: a statistical modelling approach","volume":"83","author":"Ranasinha","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.5.7962325","article-title":"Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fendo.2019.00388","article-title":"Polycystic ovary syndrome and NC-CAH: distinct characteristics and common findings","volume":"10","author":"Papadakis","year":"2019","journal-title":"A Syst Rev Front Endocrinol (Lausanne)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4158\/EP15748.DSC","article-title":"American association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2013part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"B44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bpobgyn.2016.05.003","article-title":"Androgen excess: Investigations and management","volume":"37","author":"Lizneva","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad169","article-title":"Distinct reproductive phenotypes segregate with differences in body weight in adolescent polycystic ovary syndrome","volume":"8","author":"Chen-Patterson","year":"2024","journal-title":"J Endocr Soc"},{"key":"B47","volume-title":"Polycystic ovary syndrome: dissecting the genetics, phenotype and health outcomes of a heterogeneous condition","author":"Burns","year":"2024"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092045","article-title":"Differentiating polycystic ovary syndrome from adrenal disorders","volume":"12","author":"Yesiladali","year":"2022","journal-title":"Diagn (Basel)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.8700880.x","article-title":"Frequency of a polymorphism in the regulatory region of the 17 alpha-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states","volume":"46","author":"Techatraisak","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(99)00118-1","article-title":"Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome","volume":"71","author":"Kele\u015ftimur","year":"1999","journal-title":"Fertil Steril"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad664","article-title":"Polycystic ovary syndrome physiologic pathways implicated through clustering of genetic loci","volume":"109","author":"Stamou","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12864-024-09990-w","article-title":"Body mass index stratified meta-analysis of genome-wide association studies of polycystic ovary syndrome in women of European ancestry","volume":"25","author":"Burns","year":"2024","journal-title":"BMC Genomics"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa949","article-title":"Anti-m\u00fcllerian hormone levels in adolescence in relation to long-term follow-up for presence of polycystic ovary syndrome","volume":"106","author":"Caanen","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1572427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:14:09Z","timestamp":1760674449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1572427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":53,"alternative-id":["10.3389\/fendo.2025.1572427"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1572427","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"article-number":"1572427"}}